Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merus N.V. - Common Shares (NQ:MRUS)

95.06 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 200
Open 95.06
Bid (Size) 94.01 (2)
Ask (Size) 95.39 (1)
Prev. Close 95.06
Today's Range 95.06 - 95.06
52wk Range 33.19 - 95.30
Shares Outstanding 46,530,884
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety
From Merus N.V.
Via GlobeNewswire
HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+124.7%
+124.7%
1 Month
+1.0%
+1.0%
3 Month
+43.5%
+43.5%
6 Month
+109.2%
+109.2%
1 Year
+85.4%
+85.4%

More News

Read More
Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS
From Kahn Swick & Foti, LLC
Via Business Wire
Merus Stock Soars To All-Time High As Genmab Announces $8B Takeover — Analysts Turn Cautious, Retail Crowd Cheers The Deal
Via Stocktwits
Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Merus N.V.
Via GlobeNewswire
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Merus N.V.
Via GlobeNewswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, ODP, PRO, MRUS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq - EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq - BRY), Semler Scientific, Inc. (Nasdaq – SMLR)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRO, EA, MRUS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Thursday's session.
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS
From Kahn Swick & Foti, LLC
Via Business Wire
This Maplebear Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Wall Street Lights Up as Cannabis Stocks Blaze Higher, Biotech Melts Down
Via Chartmill
Topics Cannabis
Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
Via MarketMinute
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq – EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq – BRY), Semler Scientific, Inc. (Nasdaq – SMLR)
From Brodsky & Smith LLC
Via GlobeNewswire
Top stock movements in today's session.
Via Chartmill
Tilray Brands, SNDL, Innoviz Technologies, Pony AI And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Artificial Intelligence Stocks
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough
Via Benzinga

Frequently Asked Questions

Is Merus N.V. - Common Shares publicly traded?
Yes, Merus N.V. - Common Shares is publicly traded.
What exchange does Merus N.V. - Common Shares trade on?
Merus N.V. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Merus N.V. - Common Shares?
The ticker symbol for Merus N.V. - Common Shares is MRUS on the Nasdaq Stock Market
What is the current price of Merus N.V. - Common Shares?
The current price of Merus N.V. - Common Shares is 95.06
When was Merus N.V. - Common Shares last traded?
The last trade of Merus N.V. - Common Shares was at 10/30/25 04:00 PM ET
What is the market capitalization of Merus N.V. - Common Shares?
The market capitalization of Merus N.V. - Common Shares is 4.42B
How many shares of Merus N.V. - Common Shares are outstanding?
Merus N.V. - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.